➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 7,811,560

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,811,560
Title:Compositions and methods for treating collagen-mediated diseases
Abstract: A drug product comprising a combination of highly purified collagenase I and collagenase II from Colostridium histolyticum is disclosed. The drug product includes collagenase I and collagenase II in a ratio of about 1 to 1, with a purity of greater than at least 95%. The invention further disclosed improved fermentation and purification processes for preparing the said drug product.
Inventor(s): Sabatino; Gregory L. (Chester Springs, PA), Del Tito, Jr.; Benjamin J. (Doylestown, PA), Bassett; Phillip J. (Newcastle-under-Lyme, GB), Tharia; Hazel A. (Nr Crewe, GB), Hitchcock; Antony G. (Crewe, GB)
Assignee: Auxilium US Holdings, LLC (Wilmington, DE)
Application Number:11/699,302
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,811,560
Patent Claims:see list of patent claims

Details for Patent 7,811,560

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Auxilium US Holdings, LLC (Wilmington, DE) 2026-01-30 RX search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Auxilium US Holdings, LLC (Wilmington, DE) 2026-01-30 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.